Wei Perng1, Jennifer Stuart2, Sheryl L Rifas-Shiman3, Janet W Rich-Edwards4, Alison Stuebe5, Emily Oken6. 1. Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA. Electronic address: wei.perng@gmail.com. 2. Department of Epidemiology, Harvard School of Public Health, Boston, MA. 3. Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA. 4. Connors Center for Women's Health, Brigham and Women's Hospital, Boston, MA. 5. Obstetrics and Gynecology, University of North Carolina School of Medicine, Chapel Hill. 6. Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA; Department of Nutrition, Harvard School of Public Health, Boston, MA.
Abstract
PURPOSE: To investigate whether preterm birth (PTB) is associated with greater cardiovascular disease (CVD) risk in a longitudinal cohort. METHODS: We examined differences in systolic blood pressure (SBP), diastolic blood pressure, insulin resistance (Homeostatic model assessment of insulin resistance), total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein, triglycerides, C-reactive protein, and interleukin 6 at 3 years postpartum between women who delivered preterm (gestation <37 weeks; n = 54) versus term (≥37 weeks; n = 751) using multivariable linear regression. We also assessed relations with body mass index, weight change from prepregnancy, and waist circumference at 3 and 7 years postpartum. RESULTS: Median age at enrollment was 33.9 years (range: 16.4-44.9). After adjusting for age, race, prepregnancy body mass index, parity, marital status, education, and SBP during early pregnancy, women with PTB had 3.99 mm Hg (95% confidence interval, 0.82-7.16) higher SBP and 7.01 mg/dL (1.54-12.50) lower HDL than those who delivered at term. The association with SBP was attenuated after accounting for hypertension before or during pregnancy (2.78 mm Hg [-0.30 to 5.87]). PTB was not related to other postpartum outcomes. CONCLUSIONS: PTB is related to greater CVD risk by 3 years postpartum as indicated by higher SBP and lower HDL. Although these associations may be due to preexisting conditions exacerbated during pregnancy, PTB may flag high-risk women for more vigilant CVD monitoring and lifestyle interventions.
PURPOSE: To investigate whether preterm birth (PTB) is associated with greater cardiovascular disease (CVD) risk in a longitudinal cohort. METHODS: We examined differences in systolic blood pressure (SBP), diastolic blood pressure, insulin resistance (Homeostatic model assessment of insulin resistance), total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein, triglycerides, C-reactive protein, and interleukin 6 at 3 years postpartum between women who delivered preterm (gestation <37 weeks; n = 54) versus term (≥37 weeks; n = 751) using multivariable linear regression. We also assessed relations with body mass index, weight change from prepregnancy, and waist circumference at 3 and 7 years postpartum. RESULTS: Median age at enrollment was 33.9 years (range: 16.4-44.9). After adjusting for age, race, prepregnancy body mass index, parity, marital status, education, and SBP during early pregnancy, women with PTB had 3.99 mm Hg (95% confidence interval, 0.82-7.16) higher SBP and 7.01 mg/dL (1.54-12.50) lower HDL than those who delivered at term. The association with SBP was attenuated after accounting for hypertension before or during pregnancy (2.78 mm Hg [-0.30 to 5.87]). PTB was not related to other postpartum outcomes. CONCLUSIONS: PTB is related to greater CVD risk by 3 years postpartum as indicated by higher SBP and lower HDL. Although these associations may be due to preexisting conditions exacerbated during pregnancy, PTB may flag high-risk women for more vigilant CVD monitoring and lifestyle interventions.
Authors: Emily Oken; Andrea A Baccarelli; Diane R Gold; Ken P Kleinman; Augusto A Litonjua; Dawn De Meo; Janet W Rich-Edwards; Sheryl L Rifas-Shiman; Sharon Sagiv; Elsie M Taveras; Scott T Weiss; Mandy B Belfort; Heather H Burris; Carlos A Camargo; Susanna Y Huh; Christos Mantzoros; Margaret G Parker; Matthew W Gillman Journal: Int J Epidemiol Date: 2014-03-16 Impact factor: 7.196
Authors: Anna-Karin Edstedt Bonamy; Nisha I Parikh; Sven Cnattingius; Jonas F Ludvigsson; Erik Ingelsson Journal: Circulation Date: 2011-11-28 Impact factor: 29.690
Authors: Zachary M Laubach; Wei Perng; Andres Cardenas; Sheryl L Rifas-Shiman; Emily Oken; Dawn DeMeo; Augusto A Litonjua; Radu-Corneliu Duca; Lode Godderis; Andrea Baccarelli; Marie-France Hivert Journal: Epigenomics Date: 2019-09-11 Impact factor: 4.778
Authors: Lauren J Tanz; Jennifer J Stuart; Stacey A Missmer; Eric B Rimm; Jennifer A Sumner; Mary A Vadnais; Janet W Rich-Edwards Journal: Pregnancy Hypertens Date: 2018-04-18 Impact factor: 2.899
Authors: Wei Perng; Sheryl L Rifas-Shiman; Michael S Kramer; Line K Haugaard; Emily Oken; Matthew W Gillman; Mandy B Belfort Journal: Hypertension Date: 2015-12-07 Impact factor: 10.190
Authors: Margo B Minissian; Sarah Kilpatrick; Jo-Ann Eastwood; Wendie A Robbins; Eynav E Accortt; Janet Wei; Chrisandra L Shufelt; Lynn V Doering; C Noel Bairey Merz Journal: Circulation Date: 2018-02-20 Impact factor: 29.690
Authors: Lauren J Tanz; Jennifer J Stuart; Paige L Williams; Stacey A Missmer; Eric B Rimm; Tamarra M James-Todd; Janet W Rich-Edwards Journal: J Womens Health (Larchmt) Date: 2018-09-15 Impact factor: 2.681